CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|||
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
GK Investor Relations
Ehud Helft/Gavriel Frohwein
Tel: (US) 1 646 688 3559 camtek@gkir.com
|
· |
Revenues were a record at $30.5 million, up 34% year-over-year and ahead of the upper end of the previously-issued guidance range;
|
· |
Revenues for the first half of 2018 are up over 30% from 2017;
|
· |
GAAP operating income was $4.7 million and non-GAAP operating income was $5.0 million, representing a margins of 15.5% and 16.3%, respectively; and
|
· |
GAAP net income was $4.3 million and non-GAAP net income was $4.6 million; representing margins of 14.2% and 15.0%, respectively.
|
US:
Israel: International:
|
1 888 668 9141
03 918 0609
+972 3 918 0609
|
at 10:00 am Eastern Time
at 5:00 pm Israel Time
|
June 30,
|
December 31,
|
|||||||
2018
|
2017
|
|||||||
U.S. Dollars (In thousands)
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
41,204
|
43,744
|
||||||
Trade accounts receivable, net
|
32,278
|
23,153
|
||||||
Inventories
|
23,693
|
21,336
|
||||||
Other current assets
|
2,769
|
3,215
|
||||||
Total current assets
|
99,944
|
91,448
|
||||||
Fixed assets, net
|
15,731
|
15,503
|
||||||
Long-term inventory
|
1,466
|
1,383
|
||||||
Deferred tax asset
|
3,308
|
4,067
|
||||||
Other assets, net
|
153
|
153
|
||||||
Intangible assets, net
|
480
|
482
|
||||||
5,407
|
6,085
|
|||||||
Total assets
|
121,082
|
113,036
|
||||||
Liabilities and shareholders’ equity
|
||||||||
Current liabilities
|
||||||||
Trade accounts payable
|
15,174
|
10,502
|
||||||
Other current liabilities
|
16,552
|
17,395
|
||||||
Total current liabilities
|
31,726
|
27,897
|
||||||
Long term liabilities
|
||||||||
Liability for employee severance benefits
|
870
|
838
|
||||||
870
|
838
|
|||||||
Total liabilities
|
32,596
|
28,735
|
||||||
Shareholders’ equity
|
||||||||
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2018 and at December 31, 2017;
|
||||||||
38,277,165 issued shares at June 30, 2018 and 37,924,507 at December 31, 2017;
|
||||||||
36,184,789 shares outstanding at June 30, 2018 and 35,832,131 at December 31, 2017
|
149
|
149
|
||||||
Additional paid-in capital
|
79,820
|
78,437
|
||||||
Retained earnings (losses)
|
10,415
|
7,613
|
||||||
90,384
|
86,199
|
|||||||
Treasury stock, at cost (2,092,376 as of June 30, 2018 and December 31, 2017)
|
(1,898
|
)
|
(1,898
|
)
|
||||
Total shareholders' equity
|
88,486
|
84,301
|
||||||
Total liabilities and shareholders' equity
|
121,082
|
113,036
|
Six Months ended
June 30,
|
Three Months
ended June 30,
|
Year ended
December 31,
|
||||||||||||||||||
2018
|
2017
|
2018
|
2017
|
2017
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Revenues
|
57,736
|
43,828
|
30,462
|
22,682
|
93,485
|
|||||||||||||||
Cost of revenues
|
29,840
|
22,384
|
15,563
|
11,527
|
47,966
|
|||||||||||||||
Gross profit
|
27,896
|
21,444
|
14,899
|
11,155
|
45,519
|
|||||||||||||||
Research and development costs
|
6,955
|
6,852
|
3,406
|
3,413
|
13,534
|
|||||||||||||||
Selling, general and administrative expenses
|
12,664
|
11,159
|
6,775
|
5,754
|
22,022
|
|||||||||||||||
Patent litigation expense
|
-
|
13,000
|
-
|
13,000
|
13,000
|
|||||||||||||||
Total operating expenses
|
19,619
|
31,011
|
10,181
|
22,167
|
48,556
|
|||||||||||||||
Operating income (loss)
|
8,277
|
(9,567
|
)
|
4,718
|
(11,012
|
)
|
(3,037
|
)
|
||||||||||||
Financial income (expenses), net
|
436
|
(209
|
)
|
146
|
(56
|
)
|
(150
|
)
|
||||||||||||
Income (loss) from continuing operations before income taxes
|
8,713
|
(9,776
|
)
|
4,864
|
(11,068
|
)
|
(3,187
|
)
|
||||||||||||
Income tax benefit (expense)
|
(848
|
)
|
5,364
|
(533
|
)
|
5,404
|
4,875
|
|||||||||||||
Income (loss) from continuing operations
|
7,865
|
(4,412
|
)
|
4,331
|
(5,664
|
)
|
1,688
|
|||||||||||||
Discontinued operation
|
||||||||||||||||||||
Income from discontinued operation
|
||||||||||||||||||||
Income before tax benefit (expense)
|
-
|
4,339
|
-
|
1,981
|
18,302
|
|||||||||||||||
Income tax benefit (expense)
|
-
|
(505
|
)
|
-
|
(194
|
)
|
(6,028
|
)
|
||||||||||||
Income from discontinued operation
|
-
|
3,834
|
-
|
1,787
|
12,274
|
|||||||||||||||
Net income (loss)
|
7,865
|
(578
|
)
|
4,331
|
(3,877
|
)
|
13,962
|
|||||||||||||
Net income (loss) per ordinary share:
|
||||||||||||||||||||
Basic earnings (loss) from continuing operation
|
0.22
|
(0.12
|
)
|
0.12
|
(0.16
|
)
|
0.05
|
|||||||||||||
Basic earnings from discontinued operation
|
-
|
0.11
|
-
|
0.05
|
0.35
|
|||||||||||||||
Diluted earnings (loss) from continuing operation
|
0.22
|
(0.12
|
)
|
0.12
|
(0.16
|
)
|
0.05
|
|||||||||||||
Diluted earnings from discontinued operation
|
-
|
0.11
|
-
|
0.05
|
0.34
|
|||||||||||||||
Weighted average number of ordinary shares outstanding:
|
||||||||||||||||||||
Basic
|
36,050
|
35,359
|
36,090
|
35,369
|
35,441
|
|||||||||||||||
Diluted
|
36,512
|
35,359
|
36,632
|
35,369
|
35,964
|
Six Months ended
June 30,
|
Three Months ended
June 30,
|
Year ended
December 31,
|
||||||||||||||||||
2018
|
2017
|
2018
|
2017
|
2017
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Reported net income (loss) attributable to Camtek Ltd. on GAAP basis
|
7,865
|
(578
|
)
|
4,331
|
(3,877
|
)
|
13,962
|
|||||||||||||
Effect of FIT reorganization (1)
|
506
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
395
|
184
|
249
|
92
|
426
|
|||||||||||||||
Settlement expense, net of tax (2)
|
-
|
12,025
|
-
|
12,025
|
12,025
|
|||||||||||||||
Realization of deferred tax assets (3)
|
-
|
(4,495
|
)
|
-
|
(4,495
|
)
|
(4,495
|
)
|
||||||||||||
Attributable to discontinued operations
|
-
|
(3,832
|
)
|
-
|
(1,787
|
)
|
(12,274
|
)
|
||||||||||||
Non-GAAP net income
|
8,766
|
3,304
|
4,580
|
1,958
|
9,644
|
|||||||||||||||
Non –GAAP net income per share , basic and diluted
|
0.24
|
0.09
|
0.13
|
0.06
|
0.27
|
|||||||||||||||
Gross margin on GAAP basis from continuing operations
|
48.4
|
%
|
48.9
|
%
|
48.9
|
%
|
49.2
|
%
|
48.7
|
%
|
||||||||||
Reported gross profit on GAAP basis
|
27,896
|
21,444
|
14,899
|
11,155
|
45,519
|
|||||||||||||||
Effect of FIT reorganization (1)
|
205
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
44
|
19
|
28
|
9
|
44
|
|||||||||||||||
Non- GAAP gross margin
|
28,145
|
21,463
|
14,927
|
11,164
|
45,563
|
|||||||||||||||
Non-GAAP gross profit
|
48.8
|
%
|
48.9
|
%
|
49.0
|
%
|
49.2
|
%
|
48.7
|
%
|
||||||||||
Reported operating income (loss) attributable to Camtek Ltd. on GAAP basis from continuing operations
|
8,277
|
(9,567
|
)
|
4,718
|
(11,012
|
)
|
(3,037
|
)
|
||||||||||||
Effect of FIT reorganization (1)
|
506
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
395
|
184
|
249
|
92
|
426
|
|||||||||||||||
Settlement expense (2)
|
-
|
13,000
|
-
|
13,000
|
13,000
|
|||||||||||||||
Non-GAAP operating income
|
9,178
|
3,617
|
4,967
|
2,080
|
10,389
|
(1) |
At the end of the first quarter of 2018, the Company ceased its efforts to utilize the remaining inventory and equipment related to FIT development and recorded a one-time write-off in the amount of $0.5 million, consisting of: (1) inventory write-offs of $0.2 million, recorded under the cost of revenue line item; and (2) fixed asset write-offs of $0.3 million recorded under operating expenses.
|
(2) |
During the three and the six months ended June 30, 2017, and the year ended December 31, 2017, the Company recorded a provision of $13 million ($12 million net of tax) in conjunction settlement with Rudolph Technologies Inc.
|
(3) |
During the three and the six months ended June 30, 2017, and the year ended December 31. 2017, the Company recorded net income of $4.5 million as a result of a decrease in the valuation allowance on deferred tax assets following the evaluation of the realizability of the assets based on projected future earnings.
|